T11	Biomarker 274 282	seizures
T12	Biomarker 284 300	elevated lactate
T13	Chemical 293 300	lactate
T15	Biomarker 306 329	brain MRI abnormalities
T16	Disease 346 360	Leigh syndrome
#5	AnnotatorNotes T16	DOID:3652
T17	Disease 362 364	LS
T18	Disease 429 461	dysfunction of valine metabolism
#7	AnnotatorNotes T18	C536524
T20	Chemical 444 450	valine
T21	Disease 592 594	LS
T22	Chemical 660 698	erythro‐2,3‐dihydroxy‐2‐methylbutyrate
T23	Chemical 703 722	3‐methylglutaconate
T24	Chemical 724 729	3‐MGC
T25	Biomarker 732 813	Increased urine excretion of methacrylyl‐CoA and acryloyl‐CoA related metabolites
T26	Chemical 761 776	methacrylyl‐CoA
T27	Chemical 781 793	acryloyl‐CoA
T28	Disease 855 870	SCEH deficiency
#16	AnnotatorNotes T28	DOID:0080154
T29	Variant 1002 1012	c.476A > G
T3	Disease 28 86	Short‐chain enoyl‐CoA hydratase (SCEH or ECHS1) deficiency
#17	AnnotatorNotes T3	DOID:0080154
T30	Variant 1014 1025	p.Gln159Arg
T32	Variant 1070 1080	c.538A > G
T33	Variant 1082 1094	p.(Thr180Ala
T35	Variant 1144 1154	c.538A > G
T36	Variant 1159 1168	Thr180Ala
T37	Chemical 1445 1483	erythro‐2,3‐dihydroxy‐2‐methylbutyrate
T38	Biomarker 1571 1599	increased excretion of 3‐MGC
T39	Chemical 1594 1599	3‐MGC
T4	Chemical 40 49	enoyl‐CoA
T40	Biomarker 1630 1658	normal acylcarnitine profile
T41	Chemical 1617 1624	lactate
T42	Chemical 1637 1650	acylcarnitine
T43	Disease 1678 1683	Leigh
#25	AnnotatorNotes T43	DOID:3652
T44	Disease 1748 1763	SCEH deficiency
T45	Disease 1795 1811	ECHS1 deficiency
#27	AnnotatorNotes T45	DOID:0080154
T47	Chemical 1856 1861	3‐MGA
T6	Biomarker 134 171	biallelic mutations in the gene ECHS1
T2	Gene-Protein 61 65	SCEH
#1	AnnotatorNotes T2	HGNC:3151
T48	Gene-Protein 69 74	ECHS1
#3	AnnotatorNotes T48	HGNC:3151
T49	Gene-Protein 28 59	Short‐chain enoyl‐CoA hydratase
#6	AnnotatorNotes T49	HGNC:3151
T5	Gene-Protein 166 171	ECHS1
R1	Risk-Factor Arg1:T6 Arg2:T3	
T1	Gene-Protein 1795 1800	ECHS1
T7	Gene-Protein 1170 1175	ECHS1
T8	Gene-Protein 988 993	ECHS1
T50	Gene-Protein 1788 1793	ECHS1
T51	Gene-Protein 1096 1101	ECHS1
T19	Biomarker 640 730	increased levels of erythro‐2,3‐dihydroxy‐2‐methylbutyrate and 3‐methylglutaconate (3‐MGC)
T31	Collection 1144 1169	c.538A > G, p.(Thr180Ala)
T46	Collection 1002 1026	c.476A > G (p.Gln159Arg)
#9	AnnotatorNotes T30	p.Gln159Arg
R2	Variant-Of Arg1:T8 Arg2:T46	
T53	Collection 1070 1095	c.538A > G, p.(Thr180Ala)
R3	Variant-Of Arg1:T51 Arg2:T53	
#8	AnnotatorNotes T33	p.Thr180Ala
R4	Variant-Of Arg1:T7 Arg2:T31	
T34	Collection 1678 1763	Leigh‐like presentation should prompt consideration of a diagnosis of SCEH deficiency
T54	Biomarker 1422 1483	presence of detectable erythro‐2,3‐dihydroxy‐2‐methylbutyrate
T55	Collection 1422 1658	presence of detectable erythro‐2,3‐dihydroxy‐2‐methylbutyrate is a nonspecific marker on urine organic acid analysis but this finding, together with increased excretion of 3‐MGC, elevated plasma lactate, and normal acylcarnitine profile
R5	Association Arg1:T55 Arg2:T34	
#10	AnnotatorNotes T17	DOID:3652
T9	Biomarker 218 272	infantile‐onset severe developmental delay, regression
R6	Association Arg1:T25 Arg2:T28	
T10	Biomarker 1601 1624	elevated plasma lactate
T14	Collection 218 329	infantile‐onset severe developmental delay, regression, seizures, elevated lactate, and brain MRI abnormalities
R7	Association Arg1:T12 Arg2:T3	
R8	Association Arg1:T12 Arg2:T16	
#2	AnnotatorNotes T11	D012640
